September 30, 2026

#cardiovascular — Wednesday, September 30, 2026 (2 items)

hot top new

1		ℹ	Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial. (linkinghub.elsevier.com)	Klein KR … Meskimen ER The Lancet 2026-09-30	#diabetes #cardiovascular #safety #glp-1 #pharmacotherapy
0		ℹ	Physical activity attenuates mortality risk associated with elevated resting heart rate in chronic kidney disease. (linkinghub.elsevier.com)	Zhan Y … Li G iScience 2026-09-30	#mortality #nephrology #epidemiology #risk_factors #cardiovascular